INTERNATIONAL PATENT: CHENGDU KANGHONG BIOTECHNOLOGIES CO. LTD, 成都康弘生物科技有限公司 FILES APPLICATION FOR "DOUBLE-TOXIN ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, May 26 -- CHENGDU KANGHONG BIOTECHNOLOGIES CO. LTD (No.108 Shuxi Road, Jinniu DistrictChengdu, Sichuan 610036), 成都康弘生物科技有限公司 (中国四川省成都市金牛区蜀西路108号) filed a patent application (PCT/CN2024/132357) for "DOUBLE-TOXIN ANTIBODY-DRUG CONJUGATE AND USE THEREOF" on Nov 15, 2024. With publication no. WO/2025/103474, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organizatio...